Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Retinitis pigmentosa Stories

2013-11-06 16:30:16

Company's 10 Year Anniversary Coincides with Publication of an Article by Co-founder Eberhart Zrenner, M.D. in Leading Scientific Journal, Science Translational Medicine REUTLINGEN, Germany, Nov. 6, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced it has achieved 10 years since the company formed and began working to help people impacted by RP. The journey began in 2003 when a group...

2013-10-16 11:53:21

Vitelliform macular dystrophy, also known as Best disease, is one of a group of vision-robbing conditions called bestrophinopathies that affect children and young adults. Caused by inherited mutations in the BEST1 gene, these diseases cause severe declines in central vision as patients age. With a new study, University of Pennsylvania researchers report "encouraging" findings that mark the first clear step in developing a gene therapy that could prevent vision loss or event restore vision...

2013-10-15 20:47:06

Powerful tool may lead to treatment of RP Research led by physician-scientists at Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine has produced a breakthrough discovery in diagnosing retinitis pigmentosa, a blinding disease that affects about 1 in 4,000 people in the United States. Rong Wen, M.D., Ph.D., and Byron Lam, M.D., professors of ophthalmology at Bascom Palmer, in collaboration with biochemist Ziqiang Guan, Ph.D., a research associate professor...

2013-09-26 23:32:49

On Saturday, November 9, 2013, the south Florida community will have the opportunity to walk at Hugh Taylor Birch State Park in Fort Lauderdale, in support of finding a cure for blinding retinal diseases. Fort Lauderdale, Florida (PRWEB) September 26, 2013 On Saturday, November 9, 2013, the south Florida community will have the opportunity to walk at Hugh Taylor Birch State Park in Fort Lauderdale, in support of finding a cure for blinding retinal diseases. According to the Foundation...

New PRA Gene In Phalenes And Papillons Identified
2013-08-29 08:52:33

AlphaGalileo Foundation Finnish researchers have identified a genetic mutation causing progressive retinal atrophy (PRA) in the Phalene and Papillon dog breeds. PRA is one of the most common causes of blindness in dogs and in human. This study highlights the shared genetic etiology of many canine and human genetic disorders, and provides new tools to investigate PRA mechanisms while the beloved dogs benefit from genetic testing. Professor Hannes Lohi’s research group at the University...

2013-08-09 10:10:37

Animal study reveals “unexpected” role of horizontal cells in photoreceptor rod and cone cell development of retina Scientists are developing a clearer picture of how visual systems develop in mammals. The findings offer important clues to the origin of retinal disorders later in life. In research published this week in the Journal of Neuroscience, University at Buffalo scientists and colleagues focused on a particular protein, called a transcription factor, that regulates gene...

2013-08-07 16:27:15

Technology Holds Promise for People Suffering From Macular Degeneration and Retinitis Pigmentosa IRVINE, Calif., Aug. 7, 2013 /PRNewswire/ -- EP Global Communications, Inc. and EPGL Medical (the Company), (OTC-PINK: EPGL) announced today that Company engineers have invented a new device for the purpose of treating serious eye diseases such as macular degeneration and retinitis pigmentosa. The technology emits low intensity pulse ultrasound into the eye for the purpose of regeneration...

2013-07-09 08:29:56

COLUMBIA, Md., July 9, 2013 /PRNewswire/ -- The Foundation Fighting Blindness, a nonprofit dedicated to advancing sight-saving research, has appointed New York City investment professionals Bradford Manning, co-founder of Macoma Capital Group, and Noah Rabinsky, a vice president at MidOcean Partners, as national trustees of the organization. "Brad and Noah's dedication has helped fuel our pursuit of vision-saving treatments and cures," said William T. Schmidt, CEO, Foundation...

2013-07-03 04:20:46

First Wireless Subretinal Device to Restore Useful Vision in Patients Blinded by Retinitis Pigmentosa REUTLINGEN, Germany, July 3, 2013 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced that its wireless subretinal implant technology, the Alpha IMS, has received CE Mark. Retina Implant's technology, which has been in clinical trials across the world since 2005, is designed to restore...

2013-06-13 10:02:38

Engineered virus will improve gene therapy for blinding eye diseases Researchers at the University of California, Berkeley, have developed an easier and more effective method for inserting genes into eye cells that could greatly expand gene therapy to help restore sight to patients with blinding diseases ranging from inherited defects like retinitis pigmentosa to degenerative illnesses of old age, such as macular degeneration. Unlike current treatments, the new procedure — which...